SLU-PP-332 is an investigational compound. When it comes to reconstituting peptides or research compounds:
• DMSO is a strong solvent used in lab settings to dissolve certain compounds.
• It is not typically used for injectable reconstitution.
• It can increase absorption and irritation risk.
• Bacteriostatic Water (like Hospira BAC) is the standard diluent used for most peptides intended for injection because it’s sterile and designed for that purpose.
👉 In general research practice, peptides that are water-soluble are reconstituted with BAC or sterile water, not DMSO.
A lot of people mention using DMSO because sometimes when peptides are mixed with poor-quality or improper water, you can see cloudiness or crystals form.
But here’s what’s really happening:
• Crystallization usually means the compound isn’t fully dissolving.
• That can be due to low solubility, incorrect mixing technique, temperature, or low-quality diluent.
• It does not automatically mean you need DMSO.
DMSO is a powerful lab solvent. It can dissolve compounds that don’t dissolve well in water — but it’s not the standard choice for injectable reconstitution and isn’t typically recommended unless the manufacturer specifically states it.
For most water-soluble peptides:
✔ Use high-quality bacteriostatic water (Hospira or equivalent)
✔ Let it come to room temp before mixing
✔ Add slowly down the vial wall
✔ Gently swirl — don’t shake
✔ Allow time to fully dissolve
If crystals still form, that usually points to:
• The compound’s solubility limits
• Improper storage
• Or product quality issues
Switching to DMSO just to “fix crystals” isn’t considered standard practice in typical peptide reconstitution.
This is an experimental research space, so you’ll see different approaches shared — and yes, some of that comes down to personal preference.
That said, “preference” shouldn’t replace basic safety principles.
Safety > preference, always.